Otsuka Stock Forecast, Price & News

Otsuka (OTCMKTS:OTSKY) Frequently Asked Questions

Is Otsuka a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Otsuka in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Otsuka stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OTSKY, but not buy additional shares or sell existing shares.
View analyst ratings for Otsuka or view top-rated stocks.

How has Otsuka's stock been impacted by COVID-19 (Coronavirus)?

Otsuka's stock was trading at $17.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OTSKY stock has increased by 3.1% and is now trading at $18.30.
View which stocks have been most impacted by COVID-19.

Are investors shorting Otsuka?

Otsuka saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 51,800 shares, an increase of 619.4% from the December 15th total of 7,200 shares. Based on an average daily volume of 199,300 shares, the short-interest ratio is presently 0.3 days.
View Otsuka's Short Interest.

What guidance has Otsuka issued on next quarter's earnings?

Otsuka updated its FY 2021 earnings guidance on Friday, December, 10th. The company provided earnings per share guidance of $2.720-$2.720 for the period. The company issued revenue guidance of $13.58 billion-$13.58 billion.

Who are Otsuka's key executives?

Otsuka's management team includes the following people:

• Tatsuo Higuchi, President, CEO & Representative Director
• Yuko Makino, Chief Financial Officer & Director
• Frank Czerwiec, Vice President-Global Clinical Development
• Yasuhisa Kurogi, Head-Business Development
• Shuichi Takagi, Director & Head-Business Portfolio Management

Who are some of Otsuka's key competitors?

Some companies that are related to Otsuka include Antisense Therapeutics (ANP), Bayer Aktiengesellschaft (BAYN), Mayne Pharma Group (MAYNF), Mayne Pharma Group (MYX), Medical Developments International (MVP), Opthea (OPT), Patrys (PAB), Pharmaxis (PXS), Recce Pharmaceuticals (RCE), Roche (RHHVF), Sanofi (SNYNF), Sanofi (SAN), Sinclair Pharma (SPH) and Vita Life Sciences (VLS).
View all of OTSKY's competitors.

What is Otsuka's stock symbol?

Otsuka trades on the OTCMKTS under the ticker symbol "OTSKY."

How do I buy shares of Otsuka?

Shares of OTSKY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Otsuka's stock price today?

One share of OTSKY stock can currently be purchased for approximately $18.30.

How many employees does Otsuka have?

Otsuka employs 33,151 workers across the globe.

What is Otsuka's official website?

The official website for Otsuka is www.otsuka.com.

How can I contact Otsuka?

The company can be reached via phone at (136) 717-1410.